Next, we aimed to examine whether MeTC7 can inhibit PD-L1 expression in a panel of diverse tumor cell types (AML, ovarian and pancreatic cancer) in vitro and in a syngeneic model that converges overexpression of both VDR/PD-L1 under the same settings. This evidence concerns the gene CD274 and neoplasm.